About Fusheng
Overview
Fusheng is a financial entity registered in China, operating under the domain fsuwin.com. According to our records, the company was founded on 24 November 2020. However, independent information about its operations, services, and market presence is extremely limited.
As an editorial desk that relies on verified data, we note that the absence of a publicly accessible website or marketing materials makes it difficult to assess the scope of Fusheng's offerings. Traders seeking transparency will find little to go on beyond the basic registration details.
Regulatory Status
Our records show that Fusheng holds no regulatory licences from any known financial authority. This is a critical red flag for any trading entity, as regulation provides a baseline of investor protection, including fund segregation, dispute resolution, and adherence to conduct standards.
Without oversight, clients have no recourse if disputes arise, and the broker's operational integrity is unverifiable. FXCanary's risk assessment places Fusheng at a Scam Risk Score of 51 out of 100, reflecting the elevated dangers associated with unregulated entities.
Risk Profile
The lack of regulatory oversight, combined with a high risk score, suggests that Fusheng may pose significant financial risk to users. Unregulated brokers often operate outside legal frameworks, increasing the likelihood of unfair practices, withdrawal issues, or outright fraud.
Furthermore, the entity's registration in China does not guarantee legitimacy, as Chinese authorities have limited extraterritorial reach. Traders should be aware that dealing with such an entity carries inherent risks that are not mitigated by any official protection scheme.
Conclusion
In FXCanary's assessment, Fusheng appears to be a high-risk entity with limited verifiable information. The combination of no regulation, a moderate scam risk score, and a lack of independent reviews or web presence makes it unsuitable for most traders.
Prospective clients are strongly advised to avoid engagement until the broker provides transparent regulatory disclosures and a credible track record. The onus is on the broker to demonstrate trustworthiness, and currently, it has failed to do so.
Overview compiled by FXCanary from regulatory records and public data. full Fusheng review